Research shows that mitochondrial APP prevents mitophagy in aging T-cells, suggesting enhanced antitumor immunity.
ATAD3 shuttles CerS6 to the mitochondria of aging T-cells and mitochondrial APP blocks this effect.
No takes yet. Share an insight, caveat, or question.
Kassir et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: